Evidence map›Paper›PMID 27634357›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

TrkB Signaling in Dorsal Raphe Nucleus is Essential for Antidepressant Efficacy and Normal Aggression Behavior.

Megumi Adachi, Anita E Autry, Melissa Mahgoub, Kanzo Suzuki, Lisa M Monteggia

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. 7,8-DHF Modulates Aggressive Behavior inAnimals : an open access journal from MDPI · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. iMeta · 2023
    Article
  11. Pharmaceutical biology · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. The dynamic serotonin system of the maternal brain.Archives of women's mental health · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Megumi AdachiDepartment of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Anita E AutryDepartment of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Melissa MahgoubDepartment of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kanzo SuzukiDepartment of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Lisa M MonteggiaDepartment of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
The University of Texas Southwestern Medical Center · US

Funding

ANTIDEPRESSANTS & INTRACELLULAR SIGNALING LINKED TO BDNFR01MH070727 · NIMH · VANDERBILT UNIVERSITY · PI LISA M MONTEGGIA · 2005 to 2026
$8.9M
NIMH NIH HHS R01 MH070727
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) and its high affinity receptor, tropomyosin receptor kinase B (TrkB), have important roles in neural plasticity and are required for antidepressant efficacy. Studies examining the role of BDNF-TrkB signaling in depression and antidepressant efficacy have largely focused on the limbic system, leaving it unclear whether this signaling is important in other brain regions. BDNF and TrkB are both highly expressed in the dorsal raphe nucleus (DRN), a brain region that has been suggested to have a role in depression and antidepressant action, although it is unknown whether BDNF and TrkB in the dorsal raphe nucleus are involved in these processes. We combined the adeno-associated virus (AAV) with the Cre-loxP site-specific recombination system to selectively knock down either Bdnf or TrkB in the DRN. These mice were then characterized in several behavioral paradigms including measures of depression-related behavior and antidepressant efficacy. We show that knockdown of TrkB, but not Bdnf, in the DRN results in loss of antidepressant efficacy and increased aggression-related behavior. We also show that knockdown of TrkB or Bdnf in this brain region does not have an impact on weight, activity levels, anxiety, or depression-related behaviors. These data reveal a critical role for TrkB signaling in the DRN in mediating antidepressant responses and normal aggression behavior. The results also suggest a non-cell autonomous role for BDNF in the DRN in mediating antidepressant efficacy.

Indexed as

Signal TransductionAnimalsAnimals, Genetically ModifiedAntidepressive AgentsBehavior, AnimalBrain-Derived Neurotrophic FactorDepressionDisease Models, AnimalDorsal Raphe NucleusMaleMiceReceptor, trkBAntidepressive AgentsBrain-Derived Neurotrophic FactorReceptor, trkB

Identifiers

PMID27634357
PMCPMC5312065
OpenAlexW2520820343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.